Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hyperthermia 6Rectal Neoplasms 5Colonic Neoplasms 5Carcinoma, Hepatocellular 3Ovarian Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Lung Neoplasms 2Liver Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Sarcoma 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Melanoma 1Locally Advanced Rectal Cancer 1Kidney Neoplasms 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Cholangiocarcinoma 1Anus Neoplasms 1Anastomotic Leak 1

Interventions

Oxaliplatin 29Fluorouracil 25Leucovorin 20Capecitabine 18Irinotecan 17Surveys and Questionnaires 16Bevacizumab 14Cisplatin 12Blood Specimen Collection 11Drug Therapy 10Standard of Care 9Nivolumab 9Gemcitabine 9Cetuximab 7pembrolizumab 6Specimen Handling 6S 1 (combination) 6Endoscopic Mucosal Resection 6Cyclophosphamide 6atezolizumab 5Sunitinib 5Radiotherapy 5Folfox protocol 5Educational Status 5Docetaxel 5fludarabine 4aldesleukin 4Radiosurgery 4Pemetrexed 4Magnetic Resonance Spectroscopy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Diathermy × Gastrointestinal × Clear all
NCT07118566 2025-08-12

Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases

China Medical University, China

Phase 2 Not yet recruiting
40 enrolled
Gastrointestinal

Hyperthermia, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡